(John Paul Tasker/ CBC News) — The federal government has given the green light to the Pfizer-BioNTech’s COVID-19 vaccine, a key step toward launching the largest inoculation campaign in Canada’s history.
Health Canada announced the approval Wednesday after scientists finished a two-month review of the company’s clinical trial data.
“The data provided supports favourably the efficacy of Pfizer-BioNTech COVID-19 vaccine as well as its safety,” the department said in its report authorizing use of the vaccine in Canada for people over the age of 16.
“The efficacy of the vaccine was established to be approximately 95 per cent. The vaccine was well tolerated by participants and has no important safety concerns. The benefit-to-risk assessment for Pfizer-BioNTech COVID-19 vaccine is considered favourable.”
Canada is just the third country in the world to authorize the vaccine, after the United Kingdom and Bahrain. The U.S. Food and Drug Administration will hear tomorrow from an advisory panel on whether the vaccine is safe for use in the United States and authorization is expected in “a matter of days,” U.S. Health Secretary Alex Azar said Wednesday. (…)